Latest Covid-19
Low Dose Atorvastatin Did Not Reduce Composite Endpoint in Patients with COVID-19
INSPIRATION-S led by Behnood Bikdeli, MD, MS, and presented at the American…
ACTION-Coalition Trial: Therapeutic Dose of Anticoagulation Is Associated With Increased Risk of Bleeding and No Improvement in Clinical Outcomes Among Hospitalized COVID-19 Patients With Elevated D-Dimer Levels
ACTION presented at the American College of Cardiology 2021 meeting by Renato…
Dapagliflozin in the Treatment of COVID-19: Insights from the DARE-19 Trial
SGLT-2 inhibitors have demonstrated efficacy in various cardiometabolic conditions, including heart failure,…
REPLACE COVID Trial: Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Can Be Safely Continued in Patients Admitted to Hospital With COVID-19
A recent trial by Dr. Jordana B Cohen, published in The LANCET, indicated that…
In a Recent Large Cohort Renin–Angiotensin–Aldosterone System Inhibitors Were Not Associated with Increased Risk of COVID-19 and Severe Illness
Medications acting on the renin-angiotensin-aldosterone system (RAAS), such as ACE inhibitors and…